Home › Funds › BROWN ADVISORY INC › WST

BROWN ADVISORY INC position in WST

WEST PHARMACEUTICAL SVSC INC · Health Care

BROWN ADVISORY INC reported holding 1,075,309 shares of WST (WEST PHARMACEUTICAL SVSC INC) in its Q2 2026 13F filing — a position valued at US$386.0M, representing 0.60% of its reported portfolio and ranking #37 among its reported holdings. BROWN ADVISORY INC has disclosed WST holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)1.08M sh
Reported value held$386.04M
Portfolio Weight0.60%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How BROWN ADVISORY INC's WST position evolved

BROWN ADVISORY INC first disclosed a stake in WST in Q3 2023 at 1,305,062 shares (US$489.7M). The position peaked in Q4 2024 at 2,552,036 shares, worth US$835.9M. Across 12 filings, BROWN ADVISORY INC increased the stake 6 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,075,309 shares valued at US$386.0M — a reduction of -265,568 shares quarter over quarter.. Notable position changes include a 30% increase in Q3 2024 (shares rose 9% over the following quarter), a 28% increase in Q1 2025 (shares fell 2% over the following quarter), a 31% trim in Q1 2026 (shares rose 43% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.31M $489.67M New
Q4 2023 1.41M $498.05M Add
Q1 2024 1.64M $648.12M Add
Q2 2024 1.76M $578.87M Add
Q3 2024 2.29M $686.03M Add
Q4 2024 2.55M $835.94M Add
Q1 2025 3.27M $731.75M Add
Q2 2025 3.02M $661.06M Reduce
Q3 2025 2.50M $655.33M Reduce
Q4 2025 1.94M $534.77M Reduce
Q1 2026 1.34M $336.08M Reduce
Q2 2026 1.08M $386.04M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About WST and 13F data

WST (WEST PHARMACEUTICAL SVSC INC) is a Health Care company. 34 other funds we track also report a position in WST — the largest reported positions include Artisan Partners Limited Partnership (US$865.8M), GENERATION INVESTMENT MANAGEMENT LLP (US$728.2M), Longview Partners (Guernsey) LTD (US$371.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding WST

All WST fund holders →

FAQ

How long has BROWN ADVISORY INC held WST?

BROWN ADVISORY INC has disclosed WST holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is BROWN ADVISORY INC's current position in WST?

As of Q2 2026, BROWN ADVISORY INC holds 1.08M shares of WST (WEST PHARMACEUTICAL SVSC INC), valued at $386.04M, representing 0.60% of its reported portfolio and ranking #37.

Has BROWN ADVISORY INC been buying or selling WST?

In the latest 13F filing (Q2 2026), BROWN ADVISORY INC reduced its position in WST. The position peaked in Q4 2024 at 2.55M shares.

Which other funds hold WST?

Other major institutional holders of WST include Artisan Partners Limited Partnership, GENERATION INVESTMENT MANAGEMENT LLP, Longview Partners (Guernsey) LTD, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.